Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Haipeng Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-0483-9671; OpenAlex author ID A5070002871. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice]. Last author DOI 10.3760/cma.j.cn112138-20230822-00074↗
  2. [Risk factors of pancreatitis after percutaneous transhepatic biliary drainage in patients with pancreatic cancer and obstructive jaundice]. Last author DOI 10.3760/cma.j.cn112138-20210204-00101↗
  3. Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer. Co-author DOI 10.4103/jcrt.jcrt_1663_20↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Li Zhang · 1 shared paper, 2024 · strength 0.31
  2. M Li · 1 shared paper, 2022 · strength 0.16
  3. Xueli Yang · 1 shared paper, 2022 · strength 0.16
  4. Lechang Zhang · 1 shared paper, 2022 · strength 0.16
  5. Yingtian Wei · 1 shared paper, 2021 · strength 0.08
  6. Chengli Li · 1 shared paper, 2021 · strength 0.08
  7. Tianan Jiang · 1 shared paper, 2021 · strength 0.08
  8. Yinying Lu · 1 shared paper, 2021 · strength 0.08
  9. Liwei Wang · 1 shared paper, 2021 · strength 0.08
  10. Ming Kuang · 1 shared paper, 2021 · strength 0.08
  11. Junhui Sun · 1 shared paper, 2021 · strength 0.08
  12. Kai‐Wen Huang · 1 shared paper, 2021 · strength 0.08
  13. Yingxun Zhang · 1 shared paper, 2021 · strength 0.08
  14. Maoquan Li · 1 shared paper, 2021 · strength 0.08
  15. Lizhi Niu · 1 shared paper, 2021 · strength 0.08
  16. Xiaoyi Ding · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.